TWI270364B - Integrated biosignal measuring apparatus - Google Patents
Integrated biosignal measuring apparatus Download PDFInfo
- Publication number
- TWI270364B TWI270364B TW093138230A TW93138230A TWI270364B TW I270364 B TWI270364 B TW I270364B TW 093138230 A TW093138230 A TW 093138230A TW 93138230 A TW93138230 A TW 93138230A TW I270364 B TWI270364 B TW I270364B
- Authority
- TW
- Taiwan
- Prior art keywords
- signal
- light
- measuring device
- subject
- sensing
- Prior art date
Links
- 210000004369 blood Anatomy 0.000 claims abstract description 53
- 239000008280 blood Substances 0.000 claims abstract description 53
- 230000003287 optical effect Effects 0.000 claims abstract description 49
- 210000004204 blood vessel Anatomy 0.000 claims abstract description 38
- 239000001301 oxygen Substances 0.000 claims abstract description 31
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 31
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 16
- 238000012545 processing Methods 0.000 claims description 42
- 238000004364 calculation method Methods 0.000 claims description 20
- 239000000523 sample Substances 0.000 claims description 16
- 230000005540 biological transmission Effects 0.000 claims description 14
- 238000010586 diagram Methods 0.000 claims description 13
- 238000005259 measurement Methods 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 7
- 230000011514 reflex Effects 0.000 claims description 5
- 238000012360 testing method Methods 0.000 claims description 5
- 230000003321 amplification Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 3
- 230000033764 rhythmic process Effects 0.000 claims description 3
- 238000000306 qrs interval Methods 0.000 claims description 2
- 230000005611 electricity Effects 0.000 claims 2
- 230000005693 optoelectronics Effects 0.000 claims 2
- 241000277305 Electrophorus electricus Species 0.000 claims 1
- 229910000831 Steel Inorganic materials 0.000 claims 1
- 108091008695 photoreceptors Proteins 0.000 claims 1
- 230000001953 sensory effect Effects 0.000 claims 1
- 239000010959 steel Substances 0.000 claims 1
- 238000013461 design Methods 0.000 abstract description 12
- 238000005516 engineering process Methods 0.000 abstract description 7
- 238000001514 detection method Methods 0.000 abstract description 2
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 238000007792 addition Methods 0.000 abstract 1
- 230000004962 physiological condition Effects 0.000 abstract 1
- 230000002792 vascular Effects 0.000 description 24
- 238000004458 analytical method Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000013186 photoplethysmography Methods 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000010349 pulsation Effects 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 206010021143 Hypoxia Diseases 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 150000003278 haem Chemical class 0.000 description 3
- 230000001146 hypoxic effect Effects 0.000 description 3
- 230000000149 penetrating effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000032683 aging Effects 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000004218 vascular function Effects 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000013523 data management Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003270 subclavian artery Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/026—Measuring blood flow
- A61B5/0285—Measuring or recording phase velocity of blood waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6825—Hand
- A61B5/6826—Finger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6838—Clamps or clips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physiology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
Description
1270364 九、發明說明: 【發明所屬之技術領域】 本發明係有關一種生理訊號測量裝置設計,特別是關於一種可同時測 得心電訊號與光體積描計圖訊號之整合型生理訊號量測裳置設計,利用光 學感測與電訊號感測結合之量測介面,再配合訊號分析及處理,即可簡便 的獲得如心電訊號、血管脈波、血氧濃度等多種生理參數。 【先前技術】 按,現代人由於飲食精緻、缺乏運動的生活習慣,使得心、血管疾病 危險因子增加,再加上醫療技術進步,平均壽命逐年延長,身體機能隨著 年,增長老化後,心、血管的功能逐漸降低,種種因素,使得近年來,心、 血管相關疾病已成為國人身體健康的一大威脅。 從醫療的層面來看’目前診斷心、血管功能的相_器,心臟方 主要依據的是心棚儀,心電圖儀可以紀錄心臟在產生節律性收 的電性料過程,並以心電暇現,臨床上,醫師即可依據心 作為珍斷罐魏正常與參考。而狂 , ^ 的評估血液循環功能與血液中氧氣供給狀態外,更進一步的, 能的評估上,射躺^血另卜,近來對於血_老化或彈性功 與血管反射指數(Re細lonInd==t管硬化指數 標,若將血管脈波配合心電二種參數’作為判斷血管是否老化的指1270364 IX. Description of the Invention: [Technical Field] The present invention relates to a physiological signal measuring device design, and more particularly to an integrated physiological signal measuring device capable of simultaneously measuring an ECG signal and a light plethysmogram signal The design uses the measurement interface combined with optical sensing and electrical signal sensing, and with signal analysis and processing, various physiological parameters such as ECG, vascular pulse wave and blood oxygen concentration can be easily obtained. [Previous technique] According to modern people, due to the exquisite diet and lack of exercise habits, the risk factors of heart and vascular diseases increase, and with the advancement of medical technology, the average life expectancy is prolonged year by year. The function of blood vessels is gradually reduced, and various factors have made heart and blood vessel related diseases have become a major threat to the health of Chinese people in recent years. From the medical point of view, 'the current phase of the diagnosis of heart and blood vessel function, the heart is mainly based on the heart shed instrument, the electrocardiograph can record the heart in the process of producing rhythmic electrical materials, and the heart is now In clinical practice, the physician can use the heart as a standard for the normal and reference. And mad, ^ evaluates the blood circulation function and the oxygen supply state in the blood, and further, the assessment of the energy, the lie, the blood, and the recent blood _ aging or elastic work and vascular reflex index (Re thin lonInd = =t tube hardening index, if the blood vessel pulse with ECG two parameters 'as a means of determining whether the blood vessel is aging
Vd〇^ ^ 床使用上,因羊=上^如^求得呢?就心電圖而言,在臨 極以上的心電圖儀,以1 號料資料,因此大多使用三電 用二電極,即可獲得單程。然而’從心電圖測量原理來看,利 血管方面,r ^向1的心電圖訊號。 指數_RI係多利用血法^看,目前血管硬化指數_SI與血管反射 搭配心電峨進行,=ulse)鱗得,若是脈波料歧_PWV,則再 k °血錄社要是來自心臟將錢輸送至血管時, 1270364 端產生壓力波,稱為脈波。在此以第丨圖來說明 之間的關係。財指為例,指部的脈舱形可分為二部分,第 主動脈的路徑直接到達手指,第二部份為脈波傳輸到下半身反射回、 ^者主動脈及鎖骨下動脈傳送到手指的訊號,第—個脈波波峰與第 r遠波峰之間延遲時間的長短,主要由脈波從鎖骨動脈的路徑經反射後又 j鎖㈣脈的傳導時間而決定,傳導時間除了正比於人體身高外,另血 =體血官的雜有關,人體岭雜較佳者,其對於脈㈣魏能力較佳^ 的傳導時間長,傳導速度較慢。由於血管脈波可反應出血 g本身的摊狀况’因此,藉由脈祕可推算w、&,再 號即可求得PWV。 电Λ 以現有制血管脈波波形的技術,主要可分紐力方式與光學方式, 壓力方式類似於血壓測量原理,以氣袋/壓脈袋(Cuff)包覆待測部位,填充氣 體對待測部位施壓後’彻壓力制减測血管脈動變化,例如⑽η =如1 Tech. Corp.所申請之us第麵814號、仍簡號與π觀號 專利’以及其所發表之ColinVp_1〇〇〇/2〇〇〇,可測量腳踩與上臂血壓的比值 及脈PWV之儀③’均為彻壓力方式感測脈波之應用。 而光學方式’係·光所具有反射、吸收、穿透等特性,以常使用 之紅外光線為例’由於血液巾的含氧血對於紅外光的吸收度比缺氧血來得 大,因此當心臟收縮時,對於動脈而言,其含氧血增加,即光吸收物質增 加’且錢行進速度較快,是以吸收的光量較多,而當心臟舒張期間則^ 之^此種將规打人皮膚,藉Φ接收血管愤時間、組雌化的光訊號波 形係稱為光體積描記圖技術,所得到的波形係、稱為光體積描計圖 (Potoplethysmography,PPG ) ’光體積描計圖除與血中含氧量有關外,更可 反應血管祕變化,進-何作树算SI、w、pwy與謂减來源, 例如美國公開號2004/0015091號專利’係應用光探職取ppG。 目前在市面上已有利用光體積描記圖技術偵測血管脈動波形,並用以 tf#紅f 例如美國Miw)黯㈣所發表之㈣Vd〇^ ^ Bed use, because sheep = on ^ such as ^? As far as the electrocardiogram is concerned, the electrocardiograph above the polar level is based on the No. 1 material, so most of the three electrodes are used to obtain a single pass. However, from the principle of electrocardiogram measurement, in terms of blood vessels, the ECG signal of r ^ to 1. Index _RI system uses blood method to see ^, the current vascular sclerosis index _SI and vascular reflex with ECG ,, = ulse) scale, if the pulse wave _PWV, then k ° blood recorded society from the heart When the money is delivered to the blood vessel, a pressure wave is generated at the end of 1270364, called a pulse wave. Here is a diagram to illustrate the relationship between them. For example, the cephalometric shape of the finger can be divided into two parts. The path of the aorta directly reaches the finger, the second part is the transmission of the pulse wave to the lower body, the aorta and the subclavian artery are transmitted to the finger. The signal, the length of the delay between the first pulse peak and the rth far peak is mainly determined by the conduction time of the pulse wave from the path of the clavicular artery and then the j (four) pulse. The conduction time is in addition to the human body. Outside the height, the other blood is related to the body blood, and the body is better than the ridge. The conduction time is longer and the conduction speed is slower. Since the vascular pulse wave can reflect the spread of the bleeding g itself, the PWV can be obtained by calculating the w, & Electric Λ The technology of the existing vascular pulse waveform can be divided into the main force mode and the optical mode. The pressure mode is similar to the blood pressure measurement principle. The air bag/cuff bag (Cuff) is used to cover the part to be tested, and the filling gas is to be tested. After the site is pressed, the pressure is reduced to reduce the pulsation of the blood vessel, for example, (10) η = as claimed by Tech. Corp., No. 814, still in the form of a simple and π-view patent, and its published ColinVp_1〇〇〇 /2 〇〇〇, can measure the ratio of the foot and the upper arm blood pressure and the pulse PWV instrument 3 'is the application of pulse wave sensing in the full pressure mode. The optical method, the light, has the characteristics of reflection, absorption, and penetration, and takes the infrared light that is often used as an example. 'Because the oxygen-containing blood of the blood towel absorbs infrared light more than the oxygen-deficient blood, so the heart When contracting, for arteries, the oxygen-containing blood increases, that is, the light-absorbing substance increases', and the money travels faster, so the amount of light absorbed is more, and when the heart is diastolic, it will be beaten. Skin, the optical signal waveform obtained by Φ receiving vascular anger time and group female is called photoplethysmography technique, and the obtained waveform system is called photo plethysmography (PPG). In addition to the oxygen content in the blood, it can also reflect the vascular secret changes, and the calculation of SI, w, pwy and the source of the subtraction. For example, the US Patent Publication No. 2004/0015091 is applied to the ppG. At present, the pulsation waveform of blood vessels has been detected by photoplethysmography on the market, and is used by tf#red f, for example, Miw) (4).
TracePCA,型號:PT2_ ’係為—台個光學探頭,偵測血管脈波,進一 步提供si之儀器;而另一款PulseTrace pwv型號:m〇〇〇,係同時以三 1270364 個電極與DoppleLHobe同步擷取受測者的心電圖與血管脈波,用 PWV〇 以上所述的這些參數,雖然對於評估受測者的心、血管狀況有相當助 益i且目前在臨床上使用也相當頻繁,但在不同的測量原理前提下,現有 的儀器對於心電訊號、血氧濃度與血管脈波,均以不同喊測元件進 行訊號擷取,因此,若要獲得上述所有心、血管的評估指標,必須以多種 感,儀II施行檢測,不僅耗時且相當賴。因此,聽有效且簡便的一次 獲得心、血官參數,方便且即時的瞭解自己身體狀況,本發明係結合光學 量測原理與電訊號寬測原理,設計一可擷取心電訊號、企管脈波與血氧濃 度之整合型感測裝置,藉由結合感測電極與光學探頭之感測介面,不僅可 進行心電訊號的擷取,同時可獲得光體積描計圖,進一步反應血管脈波與 血中含氧量,透過訊號的演算及分析處理,即可完整、簡便的獲得各項參 數’作為瞭解心臟及血管狀況的依據。 【發明内容】 本發明之主要目的係在提供一種整合型生理訊號測量裝置,利用結合 光學感測與電訊號感測的擷取介面,係可同時擷取心電圖訊號與光體積描 冲圖吼號,用以獲得心電圖、血管脈波波形以及血氧濃度。 本發明之另一目的在於提供一種可量測心、血管功能評估參數的裝置 設汁,藉由心電圖訊號與光體積描計圖訊號的獲得,可計算得到心、血管 功能相關評估指標。 本發明之再一目的係在提供一種可測量多種生理訊號之感測介面,藉 由心電訊號測量技術與光學感測原理的整合,使得透過單一介面即可進行 心電訊號、血管脈波波形及血氧濃度的擷取。 本發明之又一目的係在提供一種可測量並分析心、血管參數的裝置, 透過單一感測介面的設計,除可擷取心電訊號外,更可同步紀錄血管脈波 及血氧濃度,經運算分析後,即可獲得心律、ST segment、QRS interval、 血氧濃度、血管硬化指數、血管反射指數、脈波傳導速度…等心、血管相 關參數。 為達到上述之目的,本發明係以雙電極心電訊號測量技術為基礎,創 1270364 新結合光學式生理訊號測量,使透過單一感測介面即可獲得心電圖訊號與 光體積描計圖訊號,提供進一步分析心、血管參數之依據,不僅簡化現有 儀器設備,且方便使用者隨時瞭解自身心臟與血管狀況。 底下藉由具體實施例配合所附的圖式詳加說明,當更容易瞭解本發明 之目的、技術内容、特點及其所達成之功效。 【實施方式】 本發明係提出一種整合型生理訊號感測裝置,主要係運用電訊號感測 原理與光學感測原理,藉由感測元件之結合設計,達到以單一介面獲得心 電訊號、血管脈波與血氧濃度等生理訊號目的。 首先,若以光學方式感測血管脈波之原理,就首要提及比爾_朗伯定 律取沉_1^11^1^^),根據比爾_朗伯定律(^咖丄啦13如,81抓),在溶液 中,若某波長的光線會被溶液中的溶解物吸收,則穿透該溶液的穿透光① 會隨著溶解物的濃度⑹以及光線的穿透距離⑹乘積呈指數衰減,公 下: scd ⑴ 7>一 其中S :物質對光的吸收係數。 同理,當光在生物組織行進中,雖然會被如膚色、肌肉、骨骼、血液 收,但膚色、肌肉、骨I.等的光吸收量是_的,而血液職 t3- 而有不同的光吸收量。由於循環系統的作用,缺氧血在肺部 ,仃軋體父換Μ成含氧血,再隨著心臟脈動輸送至全 =;技術可卿彔血射含驗度熱,更進—步的,㈣血 =度乃隨者脈_變化,因此從含氧濃度波形可轉血管脈動波 第2 可表不血管脈紐形的光體積描記®來看,請細 在此,囉以指部賴取的紐記圖波形為例,如 ^第-個波峰到第二個波峰的延遲時間,主要取決於脈波經鎖 值 到下肢又反射_鎖骨動脈的_,假設傳導的距離正比於人體^一 官的5平性有關,因此,血管硬化可以下式進行評估: n通與血 (2) 1270364TracePCA, model: PT2_ ' is an optical probe for detecting blood vessel waves, and further provides si instrument; and another PulseTrace pwv model: m〇〇〇, which simultaneously synchronizes with DoppleLHobe with three 1270364 electrodes. Taking the electrocardiogram and vascular pulse of the subject, using PWV〇 these parameters mentioned above, although it is quite helpful for assessing the heart and blood vessel status of the subject, and is currently used quite frequently in clinical practice, but in different Under the premise of the measurement principle, the existing instruments for the ECG signal, blood oxygen concentration and vascular pulse wave are extracted by different sensor components. Therefore, in order to obtain all the evaluation indexes of heart and blood vessels, it is necessary to use various Sense, the instrument II test, not only time-consuming and quite dependent. Therefore, listening to an effective and simple one-time acquisition of heart and blood official parameters, and a convenient and immediate understanding of their physical condition, the present invention combines the principles of optical measurement and the principle of electrical signal wide measurement, and designs an ECG signal and a management pulse. The integrated sensing device for wave and blood oxygen concentration, by combining the sensing interface of the sensing electrode and the optical probe, can not only extract the ECG signal, but also obtain a photo plethysmogram to further reflect the vascular pulse wave. With the oxygen content in the blood, through the calculation and analysis of the signal, the parameters can be obtained completely and simply as the basis for understanding the heart and blood vessels. SUMMARY OF THE INVENTION The main object of the present invention is to provide an integrated physiological signal measuring device, which utilizes a sensing interface combining optical sensing and electrical signal sensing, and can simultaneously extract the electrocardiogram signal and the optical volumetric map. For obtaining electrocardiogram, blood vessel waveform and blood oxygen concentration. Another object of the present invention is to provide a device for measuring cardiac and vascular function evaluation parameters, and obtaining an evaluation index of cardiac and vascular function by obtaining an electrocardiogram signal and a photoplemogram signal. A further object of the present invention is to provide a sensing interface capable of measuring a plurality of physiological signals, and integrating the electrocardiographic signal measuring technology and the optical sensing principle, so that the electrocardiogram signal and the blood vessel pulse waveform can be transmitted through a single interface. And the blood oxygen concentration is taken. Another object of the present invention is to provide a device capable of measuring and analyzing cardiac and vascular parameters. Through the design of a single sensing interface, in addition to extracting ECG signals, the blood vessel pulse and blood oxygen concentration can be simultaneously recorded, and the operation is performed. After analysis, heart and blood vessel related parameters such as heart rate, ST segment, QRS interval, blood oxygen concentration, vascular sclerosis index, vascular reflex index, pulse wave velocity, etc. can be obtained. In order to achieve the above object, the present invention is based on the two-electrode electrocardiographic signal measurement technology, and the new combination of optical physiological signal measurement of the 1270364 enables the electrocardiogram signal and the optical plethysmogram signal to be obtained through a single sensing interface. Further analysis of the basis of heart and blood vessel parameters not only simplifies the existing instruments and equipment, but also facilitates users to understand their heart and blood vessel conditions at any time. The purpose, technical contents, features and effects achieved by the present invention will become more apparent from the detailed description of the embodiments and the accompanying drawings. [Embodiment] The present invention provides an integrated physiological signal sensing device, which mainly utilizes the principle of electrical signal sensing and the principle of optical sensing, and obtains an electrocardiogram signal and a blood vessel by a single interface by combining the sensing elements. Physiological signals such as pulse wave and blood oxygen concentration. First of all, if the principle of vascular pulse wave is optically sensed, the first mention of Bill_Lambert law takes Shen_1^11^1^^), according to Bill_Lambert law (^咖丄啦13如,81 Grab) In the solution, if a certain wavelength of light is absorbed by the dissolved matter in the solution, the penetrating light 1 penetrating the solution will exponentially decay as the product of the dissolved matter (6) and the penetration distance of the light (6) , Gong: scd (1) 7> One of which S: the absorption coefficient of light by matter. In the same way, when light travels in biological tissues, although it is collected like skin color, muscle, bones, and blood, the light absorption of skin color, muscle, bone I. etc. is _, while blood job t3- is different. The amount of light absorbed. Due to the function of the circulatory system, the oxygen-deficient blood is in the lungs, and the rolling body is replaced by oxygenated blood, and then transmitted to the whole with the heart pulse; the technique can be used to check the heat of the blood, and more advanced (4) Blood = degree is a change with the pulse _, so from the oxygen volatility waveform can be converted to vascular pulsation wave 2 can be seen in the plethysmography of the non-vascular pulse shape, please be careful here, 啰 指Take the map waveform as an example. For example, the delay time from the first peak to the second peak depends mainly on the pulse wave locked to the lower limb and the _ clavicular artery _, assuming that the conduction distance is proportional to the human body ^ An official's 5 flatness is related, therefore, hardening of the arteries can be evaluated as follows: n-pass and blood (2) 1270364
SISI
DVPDVP
Subject^Jiei2h^ in ms 57 :血管硬化指數; :為受測者身高; AT •兩波峰間延遲時間; 下才示·表示指頭的體積變化波形。 ^DVP = X 100% (3) 為第二波峰的高度 办:第一波峰的高度。 #上述式(2)及式(3)所計算之见、SI係可單從血管脈波計算估得,然而, 右要估算PWV,係需再配合心電訊號才可進行,由於PWV主要在於評估 心臟將血液送出產生的脈波,通過血管傳送至手、腳的速度。數值愈大表 示血管壁越硬,所以脈波傳導速度與前述之SI有相當大的關係。如第3圖 所示,當血管硬化程度如陶瓷般,脈波在傳導時便不易被血管壁吸收,脈 波傳導速度於是增快,若血管如橡皮管般,相當具有彈性,則脈波傳遞時 會被管壁吸收,因此脈波速度減緩。根據研究指出脈波傳導速度與心血管 疾病發生率高度相關,脈波傳導速度的數值愈高,罹患冠狀動脈的機率也 愈大。 脈波傳導速度的計算可參考第4圖式,公式如下:Subject^Jiei2h^ in ms 57 : vascular sclerosis index; : height of the subject; AT • delay between two peaks; the following shows the volume change waveform of the finger. ^DVP = X 100% (3) The height of the second peak: the height of the first peak. #The above formula (2) and formula (3) calculated, SI system can be estimated from the vascular pulse wave calculation, however, the right to estimate PWV, the need to cooperate with the ECG signal can be carried out, because PWV mainly lies in Evaluate the speed at which the heart sends blood waves from the blood vessels to the hands and feet. The larger the value, the harder the blood vessel wall, so the pulse wave velocity has a considerable relationship with the aforementioned SI. As shown in Fig. 3, when the degree of hardening of the blood vessel is like ceramic, the pulse wave is not easily absorbed by the blood vessel wall when it is transmitted, and the pulse wave velocity is increased. If the blood vessel is like a rubber tube, it is quite elastic, and the pulse wave is transmitted. It is absorbed by the tube wall, so the pulse wave speed is slowed down. According to the study, the pulse wave velocity is highly correlated with the incidence of cardiovascular disease. The higher the value of pulse wave velocity, the greater the probability of coronary artery disease. For the calculation of pulse wave velocity, refer to Figure 4, and the formula is as follows:
PTTPTT
PWV D ••脈波傳導距離; :脈波傳導時間 (4) 1270364 訂定時,需結合"電訊號,鱗解心臟將血液送出的時間, 為參考點,由於_號中,心皮_測,因此-般以R波作 要求得血管脈波的變化,利用單一光源所測得的PPG即可表示,缺 =進步的,藉由不同波段的光源的輸入,得到二個PPG後, t係可推算血液中的含氧濃度,即血氧濃度。血氧濃度是評估人體 重要參數’當人體吸氣時,氧氣由外界進人氣管,傳送至肺泡 =體父換,然舰著錢傳送至全身,供給組赫分,血氧濃度主要是計 2液中的含氧血紅素的濃度,由於,血液中含有含氧血與缺氧血,因此, 需藉由二種光源分別測得含氧血紅素濃度(册A)與缺氧血紅素濃度 (册)’再估异含氧血紅素所包含的比例,即血氧濃度(分A),公式如下: [HbQ2] \Hb〇2b[Hb]PWV D •• Pulse wave conduction distance; : Pulse wave transit time (4) 1270364 Order, need to combine "Telephone number, scale the heart to send the blood out time, as the reference point, due to _ number, carpel _ test Therefore, the R wave is required to change the vascular pulse wave. The PPG measured by a single light source can be expressed as the lack of progress. After the input of the light source of different wavelength bands, two PPGs are obtained, and the t system is obtained. The oxygen concentration in the blood, that is, the blood oxygen concentration can be estimated. Blood oxygen concentration is an important parameter for evaluating the human body. When the human body inhales, oxygen enters the human air tube from the outside, and is transmitted to the alveoli = body father, and the ship transfers the money to the whole body, and the supply group is divided into parts. The blood oxygen concentration is mainly 2 The concentration of oxygenated hemoglobin in the liquid, because the blood contains oxygenated blood and hypoxic blood, therefore, the oxygenated heme concentration (A) and the hypoxic heme concentration are measured by two light sources ( Booklet] 'Re-estimate the proportion of iso-oxygen hemoglobin, ie blood oxygen concentration (point A), the formula is as follows: [HbQ2] \Hb〇2b[Hb]
Sp〇2 (5) -ήΧίΟΟ% 册〇2 :含氧血紅素濃度 Hb :缺氧血紅素濃度 在此,係需應用式⑴之穿透光強度計算式,然而,為方便計算,在此定義 一變數OD(溶液光強度),使得式(1)可寫為:Sp〇2 (5) -ήΧίΟΟ% Book 2: Oxygenated hemoglobin concentration Hb: The concentration of hypoxic heme is here, and the calculation formula of the penetrating light intensity of formula (1) is required. However, for the convenience of calculation, it is defined here. A variable OD (solution light intensity), so that equation (1) can be written as:
=Ηγ)= scd ⑹ 在偵測血氧濃度的光源上,紅光與紅外光是較常選用的光源,特別是660nm 與940nm左右的波段,將其帶入式(6)得: ⑺ OD(660) = sHh〇i {66^)cHb〇2d + εΗΙ) (660)cHbd OD(940) = sHb〇i {9A^)cHb0d + sHb {9A^)cHbd 因此,=Ηγ)= scd (6) Red light and infrared light are the most commonly used light sources for detecting blood oxygen concentration. Especially for the 660nm and 940nm bands, bring them into equation (6): (7) OD( 660) = sHh〇i {66^)cHb〇2d + εΗΙ) (660)cHbd OD(940) = sHb〇i {9A^)cHb0d + sHb {9A^)cHbd Therefore,
Sp〇2 = _^g//h(94〇) - g册(660)_ ReHb(9^) - %ό(660)+ 8mo1 (940) - sHb〇i (660) ⑻ 其中及一 αρ(660) ’、 -0/)(940) 1270364 測元= 別為SI、M、PWV與SP〇2之運算式,由於目前感 欽而,太^日狀传不同參數仍須以不同裝置測量,造成使用上的麻煩。 ^ 二、、、口 口雙電極心電訊號感測原理與光學感測探頭設計,不僅可 t二電訊號、血管脈波與血氧濃度的娜,對於簡化醫療 U層面亦有相當幫助,其具體之裝置設計說明如后。 ^ 5 ®為本發明之裝置方塊示賴,如騎示,本發明裝置的構成首 ^匕否一感測介面模組1G,該感測介面模組1G係由二個感測電極12、12, 二光學探頭組16組成,感測電極12、12,主要負責娜—受測者的心電 減,而光學探頭、组16傳、與感測電極12、12,至少其中-者結合,用以在 心電訊號擷取同時,光的發散、反射與吸收特性侧該^者的光體 積描計圖訊號,在此,關於感測介面模組丨叫細設計將於後文詳述;一類 ^號處理模錢,係與該感測介面模組1〇電性連接,主要將該感測介面 模:且10所娜到如啦之電職與光_描計圖訊號進行類比格式的 滅處理’例如减放大、訊麟波··等;—類比/數位轉換單元%,係將 經類比訊號處理模組2G所處理完成的心魏號、光_描計圖訊號轉換成 ,位格式’關後_數位訊號處理模組4G進行數位的訊號處理及參數演 算付到包§〜律、ST segment、QRS區段等心電參婁丈,si、Rj、pwv、 SP02等血管參數;而當參數處理完成,係傳輸至—顯示單元5G,利如液晶 顯不面版、LED顯示驗H峨補算完摘制的d錄與血管 參數;另,本發明尚包含-電賴組6G,與上述各池/單元電性連接,用 以提供整體I置的電能>肖耗,電賴組6Q可以為電池形式、或為如家用插 座之外部電源形式。 在本發明中,感測介面模組10的結構乃是使本發明可同時擷取多種訊 號的獨特設計,在此,由於光學理論_訊號可區分為反射式與穿透 式,因此在整個感測介面模組10的結構上,係具有不同實施態樣。又因為 心電讯號必須至少一個電極才可記錄,而血管脈波或血氧含量係只需至少 -組光學探购可,因此,本發明巾的光學探馳16係可設於二個感測電 極12、12其中一者,或二個感測電極12、12’均設即可,在以下實施例中, 係以感測電極12、12’其中之一結合有光學探頭組16的實施態樣進行說明。 11 1270364 a首先,以反射式的光學理論來看,其卿成之感測介面模組iG結構係 如第6A圖所不,如圖所示,感測介面模組1〇係包含二感測電極im, 與-設於感測電極、12,至少射之一上的光學探頭組16,由於感測電極 12、12’主要用於擷取心電訊號,因此分別具有一接觸面14,可用以細受 測者的體表,紀錄受測者心肌產生性收縮時,傳導至肢體表面 變化,以形成心電圖;而在光學探頭组16的部分,係包含至少一光源鳩, 與至少-光接收器162,光源160係將光發射至受測者體表,而光接收器 162則接收來+自受>測者組織反射的光,即光體積描計圖訊號。 口 以下藉由弟6B圖說明弟6A圖的訊號量測機制,以運用反射式光學 原理之感測介面模組10而言,其最大優點乃是整個感測介面模組ι〇可呈 =面狀,^此,不管是要做成無·極,_於,或是受測者以觸 摸方式··等,均能方便的進行量測,在此,圖中係以受測者的指部Μ作 文測部位,且喊測電極12為例(另—感測電極12,圖巾未利。當受測者 指部18分別置於感測電極12、12,的接觸面14上時,感測電極、π係 1接收=自=臟律動所傳導至指部18的心電訊號電流,進行心電訊號的紀 錄咕以U程的心電圖測量而言,透過左右雙手所測得係為第一導程的 訊號,而在感測電極12、12,量測心電訊號同時,因感測電極i2、12,上至 少有-設有光源160與光接收器162,因此若欲進行血管脈波的侧 如紅光或紅外光其中—者至指部18,由於心臟脈動 Ϊ收之變化,進而影料的吸收與反射量,藉由光 imr積描計圖技術,獲得受測者指部18的血管脈動波 H 進行SI、w的運算式;再加上感測電極12、12’所測得 同時進行PWV的演算。而若欲測量血中含氧量,係需使 常用、,利長的光’ —光與紅外*二種波段的光最為 缺負血斜不因、/ ’使光接收13 162能接收受測者血液巾含氧血與 行SP02的計5算。、所吸收、反射的光’提供後續模組利用前述式(5)至⑻進 之二第7八圖,係為本發明相同概念但應用穿透式光學原理 吴錢剖面示意圖,如圖所示,感測介面模組1G係可更包含 12 1270364 光學探触者包覆設於爽具90内且接觸面14朝上外,更可使 假設包#於,十匕含之光源160與光接收器162設於相對應位置,在此係 :又復。又;夾具9〇内為感測電極12(另一感測電極1 ;;L" ;:22 r 12 160 , 2的相對應上方;而當光源160設於該感測電極12上時,光接Sp〇2 = _^g//h(94〇) - g(660)_ ReHb(9^) - %ό(660)+ 8mo1 (940) - sHb〇i (660) (8) where and αρ( 660) ', -0/)(940) 1270364 Measured = other arithmetic expressions of SI, M, PWV and SP 〇 2, due to the current feelings, too many parameters of the daily transmission must still be measured by different devices. Causes trouble in use. ^ Second, the oral two-electrode ECG sensing principle and optical sensing probe design, not only can t two electrical signals, blood vessel pulse and blood oxygen concentration of Na, is also very helpful for simplifying the medical U level, The specific device design description is as follows. ^ 5 ® is a device block diagram of the present invention. For example, the device of the present invention is configured as a sensing interface module 1G, and the sensing interface module 1G is composed of two sensing electrodes 12 and 12. The two optical probe sets 16 are composed of sensing electrodes 12 and 12, which are mainly responsible for the electrocardiogram reduction of the Na-subject, and the optical probe, the group 16 and the sensing electrodes 12 and 12 are combined with at least one of them. The light plethysmogram signal of the divergence, reflection and absorption characteristics of the light at the same time as the ECG signal is extracted. Here, the detailed design of the sensing interface module squeaking will be described later; The processing of the model money is electrically connected to the sensing interface module 1 , and the sensing interface module is mainly used: and the analogy format of the electric service and the optical image signal is processed. For example, the analogy/digital conversion unit% converts the heart and the light signal processed by the analog signal processing module 2G into a bit format of 'off. The post_digital signal processing module 4G performs digital signal processing and parameter calculation to the package §~law, ST segment The QRS segment and other electrocardiograms are sputum, si, Rj, pwv, SP02 and other vascular parameters; and when the parameters are processed, they are transmitted to the display unit 5G, such as LCD display no panel, LED display test H峨 complement calculation The selected d-record and the vascular parameters; in addition, the present invention further includes an electric-powered group 6G, which is electrically connected to the above-mentioned pools/units, to provide the overall I-mounted electrical energy> It is in the form of a battery or an external power supply such as a household outlet. In the present invention, the structure of the sensing interface module 10 is a unique design that enables the present invention to simultaneously capture a plurality of signals. Here, since the optical theory_signal can be distinguished into a reflective type and a transmissive type, the whole sense is The structure of the interface module 10 has different implementations. Moreover, since the electrocardiogram signal must be recorded by at least one electrode, and the blood vessel pulse wave or blood oxygen content is only required to be at least one set of optical detection, therefore, the optical leach 16 of the invention towel can be set in two senses. One of the electrodes 12, 12, or the two sensing electrodes 12, 12' may be provided. In the following embodiments, the implementation of the optical probe set 16 is combined with one of the sensing electrodes 12, 12'. The description is given. 11 1270364 a First, in terms of reflective optical theory, the iG structure of the sensing interface module of Qingcheng is as shown in Figure 6A. As shown in the figure, the sensing interface module 1 includes two sensing systems. The electrodes im, and - are disposed on the sensing electrode 12, at least one of the optical probe sets 16 . Since the sensing electrodes 12, 12' are mainly used for capturing the electrocardiographic signals, respectively, there is a contact surface 14 which is available. When the subject's body surface is recorded, the conduction to the surface of the limb changes to form an electrocardiogram; and in the portion of the optical probe set 16, at least one light source 鸠, and at least - light receiving The light source 160 emits light to the subject's body surface, and the light receiver 162 receives the light reflected from the subject tissue, that is, the light plethysmogram signal. Below the mouth, the signal measurement mechanism of the 6A diagram is illustrated by the brother 6B, and the sensing interface module 10 using the reflective optical principle has the greatest advantage that the entire sensing interface module can be rendered. Shape, ^ this, whether it is to make a non-polar, _, or the subject to touch, etc., can be easily measured, here, the figure is the finger of the subject The composition is measured, and the detecting electrode 12 is taken as an example (the other sensing electrode 12 is not advantageous. When the subject finger 18 is placed on the contact surface 14 of the sensing electrodes 12, 12, respectively, The measuring electrode, the π system 1 receiving = the electrocardiographic signal current transmitted to the finger 18 from the dirty rhythm, and the recording of the electrocardiogram signal is measured by the electrocardiogram measurement of the U-way, and the measurement by the left and right hands is the first a lead signal, and at the sensing electrodes 12, 12, measuring the ECG signal, because the sensing electrodes i2, 12, at least - are provided with a light source 160 and a light receiver 162, so if the blood vessel is desired The side of the wave, such as red light or infrared light, is transferred to the finger 18 due to changes in the heart's pulsation and absorption. By using the optical imr product plotting technique, the pulsating wave H of the subject finger 18 is obtained as an arithmetic expression of SI and w; and the PWV calculation is performed simultaneously with the sensing electrodes 12 and 12'. If you want to measure the oxygen content in the blood, you need to make the light of the common and long-term light--light and infrared* the most lack of negative blood, /' enable the light receiving 13 162 to receive the subject. The oxygen-containing blood of the blood towel is calculated according to the calculation of the SP02. The absorbed and reflected light 'provides the subsequent module using the above formula (5) to (8) into the second seventy-eighth diagram, which is the same concept of the invention but is applied. Schematic diagram of the transparent optical principle Wu Qian profile, as shown in the figure, the sensing interface module 1G system can further include 12 1270364 optical probes coated in the cool device 90 and the contact surface 14 upwards, which can make assumptions The light source 160 and the light receiver 162 are disposed at corresponding positions, and are here: again; again; the clamp 9 is a sensing electrode 12 (another sensing electrode 1;; L";: 22 r 12 160 , the corresponding upper side of 2; and when the light source 160 is disposed on the sensing electrode 12, the optical connection
係同樣利肖夹具90固定於光源160的相對應上方,如此當光源160 ^务政至受測者時,光接收器丨62係可接收來自受測者經組織吸收、穿 T的光。而以第7A圖的設計,欲進行量測時,受測者係只需將雙手指部 -一邊置於感測電極12,之接觸面14上(圖未示),另一邊置於夾具90内, 同樣接觸感測電極12之接觸面14上’即可利用感測電極12、12,獲得受測 ’且同樣的,綱單—光源、或增加絲數以及光源的切換, ρ可獲彳于又測者1個以上的光體積描計圖訊號,作為见、幻、斑 的計算依據。 〃The same sharpening fixture 90 is fixed above the corresponding light source 160, so that when the light source 160 is administrated to the subject, the light receiver 62 can receive light from the subject absorbed and worn by the tissue. In the design of FIG. 7A, when measuring, the subject only needs to place the two-finger-side on the sensing surface 12, the contact surface 14 (not shown), and the other side on the fixture 90. In the same way, the contact surface 14 of the sensing electrode 12 is also contacted with the sensing electrodes 12 and 12 to obtain the measured 'and the same, the single-light source, or the number of wires and the switching of the light source, ρ can be obtained. More than one optical plethysmogram signal is measured as a basis for calculation of seeing, illusion, and plaque. 〃
在說明感測介面模組10之設計後,為能更明確表達本發明之内容,請 多考第8圖,第8圖為第5圖之詳細方塊示意圖,如圖所示,當一受測者 使用本發明裝置時,感測介面模組1G巾的感測電極12、12,係可擷取到受 7者的心電訊號,在此同時,利用光學探頭組16係可獲得受測者的光體積 ,计圖汛號;之後,藉由一類比訊號處理模組2〇分別對所擷取到的心電訊 號與光體積描計圖訊號進行訊號處理,在此模組2〇中,首先利用一心電訊 號處理單元22,將心電訊號進行類比格式的訊號放大與濾波,另外,由於 光學探頭組16所擷取的光體積描計圖訊號為光訊號格式 ,因此’先以^一光After explaining the design of the sensing interface module 10, in order to more clearly express the content of the present invention, please refer to Figure 8 and Figure 8 is a detailed block diagram of Figure 5, as shown in the figure, when tested When the device of the present invention is used, the sensing electrodes 12 and 12 of the sensing interface module 1G can pick up the electrocardiographic signals of the seven, and at the same time, the optical probe group 16 can be used to obtain the subject. The light volume is calculated by the nickname; after that, the analog signal processing module 2 〇 separately processes the extracted ECG signal and the optical plethysmogram signal, in the module 2〇, First, the ECG signal processing unit 22 is used to amplify and filter the ECG signal in the analog format. In addition, since the optical plethysmogram signal captured by the optical probe group 16 is in the optical signal format, Light
電矾號轉換單元24,將光體積描計圖訊號由光訊號格式轉成電訊號格式, ,利用一光電訊號處理單元26,進行訊號放大與濾波;而當類比格式的訊 唬處理完畢,接續係可藉由類比/數位轉換單元30將類比訊號處理模組20 所處理完成的訊號轉換成數位格式之心電訊號與光體積描計圖訊號,然後 傳送至數位訊號處理模組40,進行進一步的訊號處理與參數演算;在數位 汛號處理模組40中,主要包含一中央處理運算單元42,用以對數位心電訊 號與數位光體積描計圖訊號進行一系列的演算處理,以得到包含心律、ST 13 1270364 、QRS關之4參數以及包含岭硬化指數、血管反射指數、脈 波傳¥速度與血祕度…等之血管參數,其演算處理流程說明如下。 在數位訊號處理模組4〇中所進行之參數演算處理流程係 r =騎楚說日\,請同時參考第丨·4圖,如_示,當數位心電訊號i 數位光體積彳4誠齡別傳达至巾央處理運算單元Μ時,對於數位 訊號而言,其處理程序係如步驟S1G所示,首先伽懷數位心、電訊號 波,正常之心電訊號是由P波、QRS波與τ波所組成,娜波 縮前去極越生的電流所引起,因此電流皱較大,較關別1 ^ -般心律計算之依據,因此係先細波驗置。接續,進行步驟si2、'、, 猎由QRS波的侧與整體心電訊號的電位準計算,得到心律、st JQRS^I"•等心電參數。另外,對於數位光體積描計圖訊號的處理,首 先,先就I-光體積描計圖訊號,用簡行血f脈波的處理而言,係如 驟S20所不,先偵測脈波到達點,脈波到達點之認定目前並無統一, 但-般係以職上升翻處、最升斜率處或最大齡祕^ 4圖 示#1 #2、#3的部分)做為脈波到達點,在此,本發明係以脈波最大上 率f作為脈波到達點之認雜據。之後,進行步驟S22,同時比對數位 ,虎與數位光體積描計圖訊號,藉由數位心電訊號摘測所得之卿波,估 异血液從續輸丨的時間,s&合脈波到達關位置,即可麟脈波傳 間(W)。接續,導入前述式(4),其中讀脈波傳導距離係配合受測者身 面與施測位置估算,即可如步驟S24得到pw。另一方面,對於數位光體 積描計圖訊號係同時進行步驟S3G,_如第2圖所示之第—波峰與第二波 峰位置,轉二波峰分獅振幅與之間的時間差,導人前述式(2)與式⑶, 即可如步驟S32,求得SI與RI。以上Pwv、SI與w係可由單_數位光 f計圖訊號進行計算。然而,更進一步的,若取得二個光體積描計圖訊 U例如以紅光與紅外光作為光源,係可如步驟S4〇所示,分別估算受測 者組織對於研光_做統射紐,即紐義計圖訊射波峰^谷 的備測’然後導入前述式⑶―式⑻,如步驟S42所示,求得血氧濃度值。 經,以上本發明參數演算流程說明後,請再參考第8圖示,在^電參 數與血官參數運算完成後,係可將所得各種參數傳送至-顯示單元5〇,顯 14 1270364 示單元5G可為液晶顯示面版、LED顯示面版等,以供受測者可以獲得相 關參數資訊。另,本發明之數位訊號處理模組4〇, 與該中央處料料元42 _接,树轉财 光體積描計圖訊號以及運算完畢的心、電參數、血f參數。進—步的,數位 訊號處理模㈣G更可·至-㈣傳輸· 7G,料傳輸歡7〇可採 USB傳輸介面、藍芽傳輸介面、紅外線傳輪介面、數據機…等,用以將儲 存於儲存單元44内的資料,包含參數與訊號輸出至一外部數位資訊裝置 72,如個人電腦、PDA、手機、資料庫···等,提供診斷分析及資料管理。 -另,本發明之整合型生理訊號量職置更可包含_㈣單元⑽,控制 單兀80係連接至该中央處理運异單凡42,使受測者藉由設定該控制單元 8〇可進而控制整個數位訊號處理模組4〇的作動,控制單元8〇可以為按鍵、« 旋鈕、觸碰式面版…等形式,用以進行例如量測功能的選擇、儲存單元私 内資料的增冊(I、傳輸’受測者個人資料的輸入以及日期設定…等。藉由電 源模組60提供整體裝置的電能消耗,以上所述之各模組/單元即可順利運 作,達成本發明所欲進行感測並分析多種訊號之功效。 本發明創新結合電制技術與光制技術,使心電訊號與光體積描記 圖訊號可藉由同-感測介面獲得,不僅簡化現有儀器設備,且其整合型可 #»多種生理訊號的測量,提供使用者可以方便迅速的瞭解自身心臟與血 管狀況,對於心血管的預防保健,以及居家醫療的發展,有相當大的應用。 ^以上所述之實施例僅係為說明本發明之技術思想及特點,其目的在使 鲁 熱習此項技蟄之人士能夠瞭解本發明之内容並據以實施,當不能以之限定 本毛月之專利範圍,即大凡依本發明所揭示之精神所作之均等變化或修 飾,仍應涵蓋在本發明之專利範圍内。 【圖式簡單說明】 ^ 1圖為血管脈動波形與傳輸路徑關係示意圖。 第2圖為血管脈波波形示意圖。 第3圖為血管脈波與血管硬化程度關係示意圖。 第4圖為血管脈波波形與心電訊號波形關係示意圖。 15 1270364 第5圖為本發明裝置之方塊示意圖。 第6A圖為本發明之感測電極結構示意圖。 第6B圖為本發明之感測電極量測示意圖。 第7圖為本發明之感測電極另一結構示意圖。 第8圖為本發明裝置之詳細方塊示意圖。 第9圖為本發明之參數演算處理流程示意圖。 【主要元件符號說明】 10感測介面模組 12、12’感測電極 14接觸面 · 16光學探頭組 160光源 162光接收器 18受測者之指部 20類比訊號處理模組 22心電訊號處理單元 24光電訊號轉換單元 26光電訊號處理單元 30類比/數位轉換單元 馨 40數位訊號處理模組 42中央處理運算單元 44儲存單元 50顯示單元 60電源模組 70資料傳輸模組 72外部數位資訊裝置 80操控單元 90夾具 16The electric volume conversion unit 24 converts the optical plethysmogram signal from the optical signal format to the electrical signal format, and uses a photoelectric signal processing unit 26 to perform signal amplification and filtering; and when the analog format processing is completed, the connection is continued. The signal processed by the analog signal processing module 20 can be converted into a digital format ECG signal and optical plethysmogram signal by the analog/digital conversion unit 30, and then transmitted to the digital signal processing module 40 for further processing. The signal processing and parameter calculation; the digital cryptographic processing module 40 mainly includes a central processing unit 42 for performing a series of calculation processing on the digital electrocardiogram and the digital photo plethysmogram signal to obtain It includes 4 parameters of heart rhythm, ST 13 1270364, QRS and vascular parameters including ridge hardening index, vascular reflex index, pulse wave velocity and blood saliency. The calculation process is described below. In the digital signal processing module 4〇, the parameter calculation processing flow is r = riding Chu said day \, please also refer to the fourth picture, such as _, when the digital ECG i digital light volume 彳 4 Cheng When the age is transmitted to the towel processing unit ,, for the digital signal, the processing procedure is as shown in step S1G, first of all, the digital heart and the electric wave are oscillated, and the normal ECG signal is composed of P wave and QRS wave. It is composed of the τ wave, and the current is caused by the current that the nano wave is rushing to the front. Therefore, the current wrinkles are larger, and the basis of the 1^-normal heart rate calculation is more important. In the continuation, step si2, ',, hunting is performed on the side of the QRS wave and the potential of the overall electrocardiogram, and the heart rate, st JQRS^I" and other ECG parameters are obtained. In addition, for the processing of the digital photo plethysmogram signal, firstly, for the processing of the I-light plethysmogram signal, with the simple blood f pulse wave, if the processing is not performed in step S20, the pulse wave is detected first. At the arrival point, the determination of the arrival point of the pulse wave is not uniform at present, but the general-purpose upswing, the highest slope or the maximum age of the 4th figure #1 #2, #3 is used as the pulse wave. At the point of arrival, the present invention uses the maximum pulse rate f of the pulse as the identification of the arrival point of the pulse wave. After that, step S22 is performed to simultaneously compare the digits, the tiger and the digital light plethysmogram signal, and the singular wave of the s& pulse arrival is estimated by the singular wave obtained by the digital electrocardiographic signal extraction. Close position, you can pass the pulse wave transmission (W). Next, the above formula (4) is introduced, wherein the read pulse wave conduction distance is estimated in accordance with the subject's body and the measured position, and pw can be obtained as in step S24. On the other hand, for the digital photoplethysmogram signal, step S3G is simultaneously performed, as shown in Fig. 2, the first peak and the second peak position, and the time difference between the two peaks and the lion amplitude is guided by the aforementioned Equation (2) and Equation (3), SI and RI can be obtained as in step S32. The above Pwv, SI and w can be calculated by the single-digit light f-figure signal. However, further, if two light plethysmograms U are obtained, for example, red light and infrared light are used as the light source, as shown in step S4 ,, the testee organization is separately estimated for the light _ , that is, the preparation of the signal of the peak of the signal, and then the introduction of the above equation (3) - equation (8), as shown in step S42, the blood oxygen concentration value is obtained. After the above description of the parameter calculation process of the present invention, please refer to the eighth figure again. After the calculation of the electrical parameter and the blood official parameter is completed, the obtained various parameters can be transmitted to the display unit 5〇, and the display 14 1270364 display unit 5G can be a liquid crystal display panel, an LED display panel, etc., so that the subject can obtain relevant parameter information. In addition, the digital signal processing module 4 of the present invention is connected to the center material unit 42 _, and the tree-turned plethysmogram signal and the calculated heart, electrical parameters, and blood f parameters. Step-by-step, digital signal processing mode (4) G can be ~ to - (four) transmission · 7G, material transmission can be used to pick up USB transmission interface, Bluetooth transmission interface, infrared transmission interface, data machine, etc., for storage The data in the storage unit 44, including parameters and signals, is output to an external digital information device 72, such as a personal computer, PDA, mobile phone, database, etc., to provide diagnostic analysis and data management. In addition, the integrated physiological signal position of the present invention may further comprise a _(four) unit (10), and the control unit 80 is connected to the central processing unit 42 so that the subject can set the control unit 8 In turn, the control unit 8〇 can control the operation of the entire digital signal processing module 4〇, and the control unit 8 can be in the form of a button, a knob, a touch panel, etc., for performing, for example, the selection of the measurement function and the increase of the private data of the storage unit. (I. Transmitting 'input of subject's personal data and date setting...etc. By providing power consumption of the whole device by the power module 60, each module/unit described above can operate smoothly, and the invention is achieved. To simulate and analyze the effects of various signals. The innovation of the invention combines the electro-mechanical technology and the optical-made technology, so that the ECG signal and the photoplethysmogram signal can be obtained by the same-sensing interface, which not only simplifies the existing instruments, but also Its integrated type can measure a variety of physiological signals, providing users with a convenient and quick understanding of their heart and blood vessel status, for cardiovascular prevention and health care, and the development of home medical care. The above-mentioned embodiments are merely for explaining the technical idea and characteristics of the present invention, and the purpose thereof is to enable the person skilled in the art to understand the contents of the present invention and implement it according to the application. </ RTI> </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; Schematic diagram of the path relationship. Fig. 2 is a schematic diagram of the waveform of the vascular pulse wave. Fig. 3 is a schematic diagram showing the relationship between the vascular pulse wave and the degree of atherosclerosis. Fig. 4 is a schematic diagram showing the relationship between the waveform of the vascular pulse wave and the waveform of the electrocardiogram signal. 15 1270364 Fig. 5 is Figure 6A is a schematic view showing the structure of the sensing electrode of the present invention. Fig. 6B is a schematic view showing the sensing electrode of the present invention. Fig. 7 is a schematic view showing another structure of the sensing electrode of the present invention. 8 is a detailed block diagram of the device of the present invention. Fig. 9 is a schematic diagram of the process of parameter calculation processing of the present invention. [Description of main component symbols] 10 sensing interface module 12, 12' sensing electrode 14 contact surface · 16 optical probe group 160 light source 162 optical receiver 18 subject's finger 20 analog signal processing module 22 ECG processing unit 24 photoelectric signal conversion unit 26 photoelectric signal processing unit 30 analog/digital conversion unit Xin 40 digital signal processing module 42 central processing arithmetic unit 44 storage unit 50 display unit 60 power supply module 70 data transmission module 72 external digital information device 80 control unit 90 fixture 16
Claims (1)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW093138230A TWI270364B (en) | 2004-12-09 | 2004-12-09 | Integrated biosignal measuring apparatus |
DE102005057757A DE102005057757A1 (en) | 2004-12-09 | 2005-12-02 | Integrated-type physiological signal evaluation apparatus for measuring cardiovascular parameters, has detection interface modules having two electrodes for obtaining electrocardiogram signal of subject |
JP2005353588A JP2006158974A (en) | 2004-12-09 | 2005-12-07 | Integral type physiologic signal evaluation apparatus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW093138230A TWI270364B (en) | 2004-12-09 | 2004-12-09 | Integrated biosignal measuring apparatus |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200618773A TW200618773A (en) | 2006-06-16 |
TWI270364B true TWI270364B (en) | 2007-01-11 |
Family
ID=36590709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093138230A TWI270364B (en) | 2004-12-09 | 2004-12-09 | Integrated biosignal measuring apparatus |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2006158974A (en) |
DE (1) | DE102005057757A1 (en) |
TW (1) | TWI270364B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI495452B (en) * | 2010-12-28 | 2015-08-11 | Ind Tech Res Inst | Apparatus and method for cardiovascular pulse measurement by using electrical pulses |
US10470693B2 (en) | 2016-12-26 | 2019-11-12 | Metal Industries Research & Development Centre | Optical sensing device for physiological signal |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8077297B2 (en) | 2008-06-30 | 2011-12-13 | Nellcor Puritan Bennett Ireland | Methods and systems for discriminating bands in scalograms |
US8827917B2 (en) | 2008-06-30 | 2014-09-09 | Nelleor Puritan Bennett Ireland | Systems and methods for artifact detection in signals |
US8295567B2 (en) | 2008-06-30 | 2012-10-23 | Nellcor Puritan Bennett Ireland | Systems and methods for ridge selection in scalograms of signals |
WO2010125705A1 (en) | 2009-04-30 | 2010-11-04 | 株式会社村田製作所 | Biosensor device |
AU2010319403A1 (en) * | 2009-11-12 | 2012-05-10 | Covidien Lp | Systems and methods for combined physiological sensors |
WO2012165064A1 (en) | 2011-05-31 | 2012-12-06 | 株式会社村田製作所 | Pulse wave sensor device |
CN103747723B (en) | 2011-08-19 | 2015-11-25 | 株式会社村田制作所 | Biosensor |
WO2013027357A1 (en) | 2011-08-19 | 2013-02-28 | 株式会社村田製作所 | Living organism sensor |
CN103505190B (en) * | 2012-06-18 | 2015-02-25 | 美盛医电股份有限公司 | Measuring device |
TWI495454B (en) * | 2013-06-11 | 2015-08-11 | Univ Nat Taiwan Science Tech | Device for detecting surface microcirculation of acupoint |
US10478075B2 (en) | 2013-10-25 | 2019-11-19 | Qualcomm Incorporated | System and method for obtaining bodily function measurements using a mobile device |
US10052035B2 (en) * | 2013-10-25 | 2018-08-21 | Qualcomm Incorporated | System and method for obtaining bodily function measurements using a mobile device |
US10342485B2 (en) | 2014-10-01 | 2019-07-09 | Covidien Lp | Removable base for wearable medical monitor |
CN107788957A (en) * | 2017-09-20 | 2018-03-13 | 上海中医药大学附属龙华医院 | One kind is based on finger pulse wave and the traditional Chinese medical science intelligence finger ring of " person's pulse on the wrist " pulse wave correlation |
KR102608633B1 (en) * | 2018-02-08 | 2023-12-04 | 삼성전자주식회사 | Electronic device and control method thereof |
EP3626159A1 (en) * | 2018-09-24 | 2020-03-25 | Koninklijke Philips N.V. | Body mountable sensor unit |
-
2004
- 2004-12-09 TW TW093138230A patent/TWI270364B/en not_active IP Right Cessation
-
2005
- 2005-12-02 DE DE102005057757A patent/DE102005057757A1/en not_active Ceased
- 2005-12-07 JP JP2005353588A patent/JP2006158974A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI495452B (en) * | 2010-12-28 | 2015-08-11 | Ind Tech Res Inst | Apparatus and method for cardiovascular pulse measurement by using electrical pulses |
US10470693B2 (en) | 2016-12-26 | 2019-11-12 | Metal Industries Research & Development Centre | Optical sensing device for physiological signal |
Also Published As
Publication number | Publication date |
---|---|
JP2006158974A (en) | 2006-06-22 |
DE102005057757A1 (en) | 2006-07-06 |
TW200618773A (en) | 2006-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI270364B (en) | Integrated biosignal measuring apparatus | |
JP6672489B2 (en) | Personal health data collection | |
JP5377320B2 (en) | Medical measuring device | |
US20060224073A1 (en) | Integrated physiological signal assessing device | |
KR101629974B1 (en) | Medical measurement device for bioelectrical impedance measurement | |
US8428673B2 (en) | Medical measuring device | |
KR20210005644A (en) | Method for estimating blood pressure and arterial stiffness based on light volumetric variability recording (PPG) signal | |
CN101605495B (en) | Medical measuring device | |
Thomas et al. | BioWatch—A wrist watch based signal acquisition system for physiological signals including blood pressure | |
US20150182132A1 (en) | Mobile device system for measurement of cardiovascular health | |
US20110288421A1 (en) | Blood pressure monitor | |
JP2016536040A (en) | System for monitoring blood pressure in real time | |
WO2012076957A1 (en) | Estimation of systemic vascular resistance and cardiac output using arterial pulse oximetry waveforms | |
KR100877207B1 (en) | Apparatus for noninvasive, continuous, and simultaneous measurement of blood pressure and arterial stiffness | |
US9521957B2 (en) | Hand-held device for self-measurement and recording of a heart rate variability examination | |
KR100855043B1 (en) | Method for noninvasive, continuous, and simultaneous measurement of blood pressure and arterial stiffness | |
Ibrahim et al. | A novel method for pulse transit time estimation using wrist bio-impedance sensing based on a regression model | |
US20110184298A1 (en) | Portable cardio waveform acquisiton and heart rate variability (hrv) analysis | |
Ganti et al. | Enabling wearable pulse transit time-based blood pressure estimation for medically underserved areas and health equity: comprehensive evaluation study | |
KR100855042B1 (en) | Apparatus for noninvasive, continuous, and simultaneous measurement of blood pressure and arterial stiffness | |
KR100877212B1 (en) | Apparatus for noninvasive, continuous, and simultaneous measurement of blood pressure and arterial stiffness | |
Vedpathak et al. | Smart ambulatory blood pressure monitor: A novel approach | |
CN116421157A (en) | Noninvasive hemodynamic monitoring system | |
KR20070101696A (en) | Method and apparatus for measuring blood pressures by using blood oxygen concentration and electrocardiography | |
JP2007252767A (en) | Blood oxygen concentration analyzer, and method and apparatus for measuring blood pressure value by electrocardiograph |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |